Molecular Testing of Coronavirus SARS-CoV-2
Patient Information Sample Information
Patient Name ΗΛΙΑΣ ΠΑΠΑΙΩΑΝΝΟΥ Unique Order ID 6758991
Date of Birth 12/05/2016 Date of Collection 19/01/2022 - 07:50
Date of Receipt 19/01/2022
Phone 99545482
Email [email protected]
Identity 1311320
Result NEGATIVE
Genetic material (RNA) of SARS-CoV-2 is NOT detected
Notify your doctor of your results and follow their instructions. Negative
result does not exclude the possibility of infection.
METHODOLOGY
The NIPD Genetics COVID-19 test is a molecular genetic test for the detection of SARS-CoV-2 which causes
COVID-19. The test checks for the viral RNA signature to confirm the presence of SARS-CoV-2. Viral RNA is
isolated using a standardized methodology and is subjected to Reverse Transcription- quantitative PCR
(RT-qPCR followed by Real-Time PCR Panel) for detection of SARS-CoV-2. The NIPD Genetics molecular
genetic test is specifically designed to detect SARS-CoV-2. It does not detect any other types of coronaviruses.
Approved by: Elena Kypri, Ph.D, ASCP
Approved by: Philippos Patsalis, Ph.D, HCLD, Laboratory Director
Date of report 19/01/2022
Neas Engomis 31, Nicosia, 2409 Cyprus
Phone: +357 22266888 Fax: +357 22266899
Web: www.nipd.com Email:
[email protected]